Showing results (31-40 of 1,009) with videos related to

Sort By:
Pageof 101
Cancer Research Communications|May 5, 2025
APOBEC3 Activity Promotes the Survival and Evolution of Drug-Tolerant Persister Cells during EGFR Inhibitor Resistance in Lung CancerNina Marie G Garcia, Jessica N Becerra, Sharan Srinivasan, et al.
Cancer Research Communications|May 5, 2025
Modeled Benefit of Individual Cancer Signal Origin Prediction for Multi-Cancer Early DetectionEric A Klein, Timothy R Church, Christina A Clarke, et al.
Cancer Research Communications|October 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal CancerRobert W Lentz, Julie Lang, Todd M Pitts, et al.
Cancer Research Communications|October 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid TumorsKristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.
Cancer Research Communications|August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic CancerJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Cancer Research Communications|August 18, 2025
Impact of Staging, Histologic Grading, and Racial Background on Lip Cancer Survival in the United States: Insights from the SEER Database (2010-2020)Muhammad Taqi, Syed Jaffar Abbas Zaidi
Cancer Research Communications|September 8, 2025
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against OsteosarcomaMichelle Choe, Danielle Kirkey, Isabel Lira, et al.
Cancer Research Communications|September 18, 2025
A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid TumorsChristopher H Lieu, Heinz-Josef Lenz, Al B Benson, et al.
Cancer Research Communications|September 19, 2025
Functional Analysis of Rare RAS Variants of Unknown SignificanceSoohwan Park, Masachika Ikegami, Rina Kitada, et al.
Cancer Research Communications|September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for OsteosarcomaEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Pageof 101